JENNIFER DICKERSON: Open Payments
NPI 1386309169 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$662 in 19 payments from 9 companies in 2025. Trend: 2023 $196 · 2024 $629 · 2025 $662
Food & beverage: $662
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $319 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $125 |
| GlaxoSmithKline, LLC. | 2 | $55 |
| GENZYME CORPORATION | 2 | $49 |
| Optinose US, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $18 |
Products named: DUPIXENT, NEFFY, NUCALA, XHANCE, ZEPBOUND, TEZSPIRE, Ryaltris.
Industry payments across OK — which companies pay providers there.
